These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145 [TBL] [Abstract][Full Text] [Related]
11. Prospects for gene therapy in inflammatory arthritis. Jorgensen C; Apparailly F Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):541-52. PubMed ID: 20732651 [TBL] [Abstract][Full Text] [Related]
13. Technology insight: gene transfer and the design of novel treatments for rheumatoid arthritis. Moritz F; Distler O; Ospelt C; Gay RE; Gay S Nat Clin Pract Rheumatol; 2006 Mar; 2(3):153-62. PubMed ID: 16932675 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy: what have we accomplished and where do we go from here? Evans CH J Rheumatol Suppl; 2005 Jan; 72():17-20. PubMed ID: 15660458 [TBL] [Abstract][Full Text] [Related]
15. The promise of a new clinical trial--intra-articular IL-1 receptor antagonist. Evans CH; Robbins PD Proc Assoc Am Physicians; 1996 Jan; 108(1):1-5. PubMed ID: 8834057 [TBL] [Abstract][Full Text] [Related]
16. [Gene therapy in rheumatoid arthritis: new aspects]. Pundt N; Peters MA; Wunrau C; Pap T Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1737-41. PubMed ID: 18696407 [TBL] [Abstract][Full Text] [Related]